308
Views
5
CrossRef citations to date
0
Altmetric
Review

Strategies to manage obstructive sleep apnea to decrease the burden of atrial fibrillation

, &
Pages 707-713 | Received 18 Apr 2018, Accepted 20 Aug 2018, Published online: 03 Sep 2018

References

  • Al-Falahi Z, Williamson J, Dimitri H. Atrial fibrillation and sleep apnoea: guilt by association? Heart Lung Circ. 2017;26:902–910.
  • Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med. 2015;3:310–318.
  • Costa LE, Uchoa CH, Harmon RR, et al. Potential underdiagnosis of obstructive sleep apnoea in the cardiology outpatient setting. Heart. 2015;101:1288–1292.
  • Szymanski FM, Platek AE, Karpinski G, et al. Obstructive sleep apnea in patients with atrial fibrillation: prevalence, determinants and clinical characteristics of patients in Polish population. Kardiol Pol. 2014;72:716–724.
  • Gami AS, Pressman G, Caples SM, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation. 2004;110:364–367.
  • Monahan K, Storfer-Isser A, Mehra R, et al. Triggering of nocturnal arrhythmias by sleep-disordered breathing events. J Am Coll Cardiol. 2009;54:1797–1804.
  • Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol. 1983;52:490–494.
  • Hoffstein V, Mateika S. Cardiac arrhythmias, snoring, and sleep apnea. Chest. 1994;106:466–471.
  • Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173:910–916.
  • Gami AS, Hodge DO, Herges RM, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49:565–571.
  • Drager LF, Polotsky VY, O’Donnell CP, et al. Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2015;309:H1101–11.
  • Drager LF, Bortolotto LA, Figueiredo AC, et al. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest. 2007;131:1379–1386.
  • Arias MA, García-Río F, Alonso-Fernández A, et al. Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation. 2005;112:375–383.
  • Drager LF, Bortolotto LA, Pedrosa RP, et al. Left atrial diameter is independently associated with arterial stiffness in patients with obstructive sleep apnea: potential implications for atrial fibrillation. Int J Cardiol. 2010;144:257–259.
  • Christ T, Rozmaritsa N, Engel A, et al. Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation. Proc Natl Acad Sci U S A. 2014;111:11193–11198. Erratum in: Proc Natl Acad Sci U S A. 2014;111:14003.
  • Park HW, Shen MJ, Lin SF, et al. Neural mechanisms of atrial fibrillation. Curr Opin Cardiol. 2012;27:24–28.
  • Gutierrez A, Van Wagoner DR. Oxidant and inflammatory mechanisms and targeted therapy in atrial fibrillation: an update. J Cardiovasc Pharmacol. 2015;66:523–529.
  • Issac TT, Dokainish H, Lakkis NM, et al. Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J Am Coll Cardiol. 2007;50:2021–2028.
  • Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105:2462–2464.
  • Bradley TD, Floras JS. Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation. 2003;107:1671–1678.
  • Iwasaki YK, Kato T, Xiong F, et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol. 2014;64:2013–2023.
  • Orban M, Bruce CJ, Pressman GS, et al. Dynamic changes of left ventricular performance and left atrial volume induced by the Mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. Am J Cardiol. 2008;102:1557–1561.
  • Linz D, Schotten U, Neuberger HR, et al. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm. 2011;8:1436–1443.
  • Dimitri H, Ng M, Brooks AG, et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9:321–327.
  • Drager LF, McEvoy RD, Barbe F, et al. INCOSACT Initiative (International Collaboration of Sleep Apnea Cardiovascular Trialists). Sleep apnea and cardiovascular disease: lessons from recent trials and need for team science. Circulation. 2017;136:1840–1850.
  • Ghias M, Scherlag BJ, Lu Z, et al. The role of ganglionated plexi in apnea-related atrial fibrillation. J Am Coll Cardiol. 2009;54:2075–2083.
  • Linz D, Hohl M, Nickel A, et al. Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension. 2013;62:767–774.
  • May AM, Van Wagoner DR, Mehra R, et al. OSA and cardiac arrhythmogenesis: mechanistic Insights. Chest. 2017;151:225–241.
  • Szymanski FM, Filipiak KJ, Platek AE, et al. Assessment of CHADS2 and CHA 2DS 2-VASc scores in obstructive sleep apnea patients with atrial fibrillation. Sleep Breath. 2015;19:531–537.
  • Yaranov DM, Smyrlis A, Usatii N, et al. Effect of obstructive sleep apnea on frequency of stroke in patients with atrial fibrillation. Am J Cardiol. 2015;115:461–465.
  • Monahan K, Brewster J, Wang L, et al. Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2012;110:369–372.
  • Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107:2589–2594.
  • Sauer WH, McKernan ML, Lin D, et al. Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm. 2006;3:1024–1028.
  • Ng CY, Liu T, Shehata M, et al. Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. Am J Cardiol. 2011;108:4–e51.
  • Anter E,  Di Biase L, Contreras-Valdes FM, et al. Atrial substrate and AF triggers in sleep apnea. Circ Arrhythm Electrophysiol. 2017;10:e005407.
  • Naruse Y, Tada H, Satoh M, et al. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm. 2013;10:331–337.
  • Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62:300e5.
  • Linz D, McEvoy RD, Cowie MR, et al. Associations of obstructive sleep apnea with atrial fibrillation and continuous positive airway pressure treatment: a review. JAMA Cardiol. 2018;3:532–540.
  • Pedrosa RP, Andrade FMD. The role of physical exercise in obstructive sleep apnea. J Bras Pneumol. 2016;42:457–464.
  • Maki-Nunes C, Toschi-Dias E, Cepeda FX, et al. Diet and exercise improve chemoreflex sensitivity in patients with metabolic syndrome and obstructive sleep apnea. Obesity. 2015;23:1582–1590.
  • Toschi-Dias E, Trombetta IC, Silva VJD, et al. Diet associated with exercise improves baroreflex control of sympathetic nerve activity in metabolic syndrome and sleep apnea patients. Sleep Breath. 2018 Jun 11 Epub ahead of print. doi:10.1007/s11325-018-1675-x
  • Ueno LM, Drager LF, Rodrigues AC, et al. Effects of exercise training in patients with chronic heart failure and sleep apnea. Sleep. 2009;32:637–647.
  • Malmo V, Nes BM, Amundsen BH, et al. Aerobic interval training reduces the burden of atrial fibrillation in the short term a randomized trial. Circulation. 2016;133:466–473.
  • Abe H, Takahashi M, Yaegashi H, et al. Efficacy of continuous positive airway pressure on arrhythmias in obstructive sleep apnea patients. Heart Vessels. 2010;25:63–69.
  • Lee CH, Sethi R, Li R, et al. Obstructive sleep apnea and cardiovascular events after percutaneous coronary intervention. Circulation. 2016;133:2008–2017.
  • Koo CY, Drager LF, Sethi R, et al. Sleep and stent study investigators. Obstructive sleep apnea and diabetes independently add to cardiovascular risk after coronary revascularization. Diabetes Care. 2018;41:e12–e14.
  • Uchôa CHG, Pedrosa RP, Javaheri S, et al. OSA and prognosis after acute cardiogenic pulmonary edema: the OSA-CARE study. Chest. 2017;152:1230–1238.
  • Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–1053.
  • Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–2041.
  • Desteghe L, Hendriks JML, McEvoy RD, et al. The why, when and how to test for obstructive sleep apnea in patients with atrial fibrillation. Clin Res Cardiol. 2018 April 12. doi:10.1007/s00392-018-1248-9
  • Genta PR, Drager LF, Lorenzi Filho G. Screening for obstructive sleep apnea in patients with atrial fibrillation. Sleep Med Clin. 2017;12:99–105.
  • Tang RB, Dong JZ, Liu XP, et al. Obstructive sleep apnoea risk profile and the risk of recurrence of atrial fibrillation after catheter ablation. Europace. 2009;11:100–105.
  • Marti-Soler H, Hirotsu C, Marques-Vidal P, et al. The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study. Lancet Respir Med. 2016;4:742–748.
  • Giampá SQC, Pedrosa RP, Gonzaga CC, et al. Performance of NoSAS score versus Berlin questionnaire for screening obstructive sleep apnoea in patients with resistant hypertension. J Hum Hypertens. 2018;32:518–523.
  • Bhatt DL, Kandzari DE, O’Neill WW, et al. SYMPLICITY HTN-3 investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393–1401.
  • Nammas W, Airaksinen JK, Paana T, et al. Renal sympathetic denervation for treatment of patients with atrial fibrillation: reappraisal of the available evidence. Heart Rhythm. 2016;13:2388–2394.
  • Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. 2011;58:559–565.
  • Warchol-Celinska E, Prejbisz A, Kadziela J, et al. Renal denervation in resistant hypertension and obstructive sleep apnea: randomized proof-of-concept phase II trial. Hypertension. 2018 Aug;72(2):381–390.
  • Daniels F, De Freitas S, Smyth A, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnoea severity and metabolic indices: a prospective cohort study. Sleep Med. 2017;30:180–184.
  • Drager LF. New challenges for sleep apnea research: simple diagnostic tools, biomarkers, new treatments and precision medicine. Sleep Sci. 2017;10:55–56.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.